AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2015
Oct 22, 2015
34097_dirs_2015-10-22_225ba59e-437b-4653-a412-a09fefcc8298.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-10-20
Reporting Person: Berecz Elizabeth (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-20 | Common Stock | A | 350000 | $0.00 | Acquired | 350000 | Direct |
Footnotes
F1: Restricted Stock Award issued pursuant to the the terms and conditions of the Company's 2014 Omnibus Incentive Plan and is subject to three year cliff vesting on October 20, 2018.
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10